Business Description
Prothena Corporation plc is an Irish biotechnology company founded in 2012 and headquartered in Dublin, focused on developing treatments for serious diseases caused by abnormal protein behavior in the body. The company has a broad pipeline of experimental medicines targeting conditions such as Parkinson's disease, Alzheimer's disease, and other neurological disorders, with several candidates currently in advanced clinical trials. Prothena works alongside major pharmaceutical partners, including Roche and Bristol Myers Squibb, to advance and commercialize these therapies on a global scale.
